Did not become law. It stopped in the House of Representatives's Judiciary Committee on March 16, 2018. The 2017–2018 session has ended.
2017–2018 Regular Session
House Bill 2147
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
15 co-sponsors
Christopher B. Quinn, STEPHEN E. BARRAR, HARRY A. READSHAW III, Michael J. Driscoll, Aaron Bernstine, TARAH C. TOOHIL, STANLEY E. SAYLOR, THOMAS P. MURT, ANTHONY M. DELUCA, MARCY TOEPEL, Carol Hill-Evans, Matthew D. Dowling, Craig T. Staats, MARGUERITE CORR QUINN, Alexander T. Charlton
Its course
March 16 to March 16, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the House of RepresentativesMar 16 to Mar 16 · stopped0 days
JudiciaryMar 16 to Mar 16 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.